Fig. 4: Clinical correlations and predictive accuracy of hypokinetic and hyperkinetic compound scores.
From: Digital speech biomarkers can measure acute effects of levodopa in Parkinson’s disease
a Correlation plot between change in the hypokinetic compound score and change in the MDS-UPDRS-III without tremor items. b Actual value of the change in MDS-UPDRS-III without tremor items (grey) vs the predicted value using only the hypokinetic compound score and respective 95% CI (blue). c Correlation plot between change in the hyperkinetic compound score and change in the Marconi dyskinesia rating scale axial subscore. d Actual value of the change in Marconi dyskinesia rating scale axial subscore (grey) vs the predicted value using only the hyperkinetic compound score and respective 95% CI (purple). CI Confidence Interval, MAE Mean absolute error, RMSE Root mean squared error. Created in https://BioRender.com.
